Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 4
1982 4
1983 1
1984 2
1985 4
1986 3
1988 7
1989 3
1990 2
1991 6
1992 4
1993 5
1994 1
1995 3
1996 4
1997 6
1998 2
1999 7
2000 5
2001 4
2002 18
2003 10
2004 6
2005 3
2006 6
2007 7
2008 10
2009 11
2010 8
2011 9
2012 11
2013 9
2014 7
2015 7
2016 8
2017 4
2018 5
2019 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Results by year
Filters applied: . Clear all
Page 1
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ, Mino-Kenudson M, Engelman JA. Sequist LV, et al. Among authors: mark ej. Sci Transl Med. 2011 Mar 23;3(75):75ra26. doi: 10.1126/scitranslmed.3002003. Sci Transl Med. 2011. PMID: 21430269 Free PMC article.
ROS1 rearrangements define a unique molecular class of lung cancers.
Bergethon K, Shaw AT, Ou SH, Katayama R, Lovly CM, McDonald NT, Massion PP, Siwak-Tapp C, Gonzalez A, Fang R, Mark EJ, Batten JM, Chen H, Wilner KD, Kwak EL, Clark JW, Carbone DP, Ji H, Engelman JA, Mino-Kenudson M, Pao W, Iafrate AJ. Bergethon K, et al. Among authors: mark ej. J Clin Oncol. 2012 Mar 10;30(8):863-70. doi: 10.1200/JCO.2011.35.6345. Epub 2012 Jan 3. J Clin Oncol. 2012. PMID: 22215748 Free PMC article.
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
Shaw AT, Yeap BY, Mino-Kenudson M, Digumarthy SR, Costa DB, Heist RS, Solomon B, Stubbs H, Admane S, McDermott U, Settleman J, Kobayashi S, Mark EJ, Rodig SJ, Chirieac LR, Kwak EL, Lynch TJ, Iafrate AJ. Shaw AT, et al. Among authors: mark ej. J Clin Oncol. 2009 Sep 10;27(26):4247-53. doi: 10.1200/JCO.2009.22.6993. Epub 2009 Aug 10. J Clin Oncol. 2009. PMID: 19667264 Free PMC article.
Tracheobronchial gland tumors.
Gaissert HA, Mark EJ. Gaissert HA, et al. Among authors: mark ej. Cancer Control. 2006 Oct;13(4):286-94. doi: 10.1177/107327480601300406. Cancer Control. 2006. PMID: 17075566 Free article. Review.
Pulmonary veno-occlusive disease.
Mandel J, Mark EJ, Hales CA. Mandel J, et al. Among authors: mark ej. Am J Respir Crit Care Med. 2000 Nov;162(5):1964-73. doi: 10.1164/ajrccm.162.5.9912045. Am J Respir Crit Care Med. 2000. PMID: 11069841 Review. No abstract available.
In vivo optical coherence tomography: the role of the pathologist.
Hariri LP, Mino-Kenudson M, Mark EJ, Suter MJ. Hariri LP, et al. Among authors: mark ej. Arch Pathol Lab Med. 2012 Dec;136(12):1492-501. doi: 10.5858/arpa.2012-0252-SA. Arch Pathol Lab Med. 2012. PMID: 23194041 Free article. Review.
Pulmonary cholesterol crystal embolization.
Sabatine MS, Oelberg DA, Mark EJ, Kanarek D. Sabatine MS, et al. Among authors: mark ej. Chest. 1997 Dec;112(6):1687-92. doi: 10.1378/chest.112.6.1687. Chest. 1997. PMID: 9404775 Review.
Hypersensitivity Pneumonitis A Perspective From Members of the Pulmonary Pathology Society.
Miller R, Allen TC, Barrios RJ, Beasley MB, Burke L, Cagle PT, Capelozzi VL, Ge Y, Hariri LP, Kerr KM, Khoor A, Larsen BT, Mark EJ, Matsubara O, Mehrad M, Mino-Kenudson M, Raparia K, Roden AC, Russell P, Schneider F, Sholl LM, Smith ML. Miller R, et al. Among authors: mark ej. Arch Pathol Lab Med. 2018 Jan;142(1):120-126. doi: 10.5858/arpa.2017-0138-SA. Epub 2017 Jun 14. Arch Pathol Lab Med. 2018. PMID: 28613913 Free article. Review.
Primary pulmonary lymphoma.
Graham BB, Mathisen DJ, Mark EJ, Takvorian RW. Graham BB, et al. Among authors: mark ej. Ann Thorac Surg. 2005 Oct;80(4):1248-53. doi: 10.1016/j.athoracsur.2005.04.014. Ann Thorac Surg. 2005. PMID: 16181848
208 results